Locations
Farmington, CT, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2013
Torigen Pharmaceuticals, Inc. is dedicated to providing innovative cancer care solutions for animals, focusing on personalized immunotherapy and expert diagnostics. Their key products include autologous cancer vaccines and a specialty pathology service that streamlines cancer diagnostics for veterinarians. The company differentiates itself through its commitment to rapid turnaround times and tailored treatment options, aiming to enhance the quality of care for pets with cancer. With a strong emphasis on harnessing the immune system, Torigen is positioned at the forefront of veterinary oncology, catering to a growing market of pet owners seeking advanced cancer treatments for their animals.
Something looks off?